1988
DOI: 10.1378/chest.94.4.727
|View full text |Cite
|
Sign up to set email alerts
|

Arrhythmias in the Assessment of Coronary Artery Reperfusion Following Thrombolytic Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1991
1991
2016
2016

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Various studies have shown the association of sinus bradycardia and accelerated idioventricular rhythm with the occurrence of myocardial reperfusion, 8,9 as well as the lack of specificity of the ventricular arrhythmias as reperfusion markers. [10][11][12] However, it is not completely clear whether VT is a marker of inadequate myocardial perfusion after thrombolysis; 13 therefore, a more aggressive attitude has been recommended in these patients based on their high mortality rate.…”
Section: Discussion Sustained Ventricular Tachycardia As a Marker Of mentioning
confidence: 99%
“…Various studies have shown the association of sinus bradycardia and accelerated idioventricular rhythm with the occurrence of myocardial reperfusion, 8,9 as well as the lack of specificity of the ventricular arrhythmias as reperfusion markers. [10][11][12] However, it is not completely clear whether VT is a marker of inadequate myocardial perfusion after thrombolysis; 13 therefore, a more aggressive attitude has been recommended in these patients based on their high mortality rate.…”
Section: Discussion Sustained Ventricular Tachycardia As a Marker Of mentioning
confidence: 99%
“…Studies in the thrombolytic era have suggested that AIVR is a marker of reperfusion following thrombolytic therapy [26][27][28][29], although this has debated in the literature [29][30][31]. Explanations for these differences include the definition of AIVR used, the possible failure to record "benign" arrhythmias, the use of both intracoronary and intravenous thrombolytics, and the use of lidocaine in some trials [27].…”
Section: Incidence and Prognosismentioning
confidence: 99%